We are live on
!
Find out more
ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
1-Year Est. Return
10.23%
This Fund
S&P 500
This Quarter
Est. Return
+2.84%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$1.71B
AUM Growth
+$11.8M
(+0.7%)
Cap. Flow
+$9.72M
Cap. Flow
% of AUM
0.57%
Top 10 Holdings %
Top 10 Hldgs %
21.59%
Holding
168
New
11
Increased
69
Reduced
76
Closed
12
Top Buys
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$21M |
| 2 |
EXAS
Exact Sciences
EXAS
|
+$18.8M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
+$13.7M |
| 4 |
Pacira BioSciences
PCRX
|
+$12.2M |
| 5 |
FMI
Foundation Medicine, Inc.
FMI
|
+$10M |
Top Sells
| 1 |
HAWK
Blackhawk Network Holdings, Inc. Common Stock
HAWK
|
+$29.7M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$25.2M |
| 3 |
CALD
Callidus Software, Inc.
CALD
|
+$20.9M |
| 4 |
EFOR
Everforth Inc
EFOR
|
+$18.4M |
| 5 |
Chegg
CHGG
|
+$15.5M |
Sector Composition
| 1 | Healthcare | 20.35% |
| 2 | Industrials | 20% |
| 3 | Technology | 17.18% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INXN
1
DELISTED
Interxion Holding N.V.
INXN
| $54.8M | 3.2% |
881,841
-15,116
| -2% | -$902K |
|
2
MaxLinear
MXL
$6.58B
| $44.8M | 2.62% |
1,970,852
-44,213
| -2% | -$1.1M |
|
|
EXAS
3
DELISTED
Exact Sciences
EXAS
| $38.8M | 2.27% |
962,731
+384,481
| +66% | +$18.8M |
|
4
Cerus
CERS
$625M
| $38.7M | 2.26% |
7,062,928
+515,550
| +8% | +$2.34M |
|
|
QUOT
5
DELISTED
Quotient Technology Inc
QUOT
| $36.9M | 2.15% |
2,814,940
+583,941
| +26% | +$7.39M |
|
|
WNS
6
DELISTED
WNS Holdings
WNS
| $33.9M | 1.98% |
748,713
-153,341
| -17% | -$6.73M |
|
7
Evolent Health
EVH
$627M
| $33.4M | 1.95% |
2,345,663
+364,583
| +18% | +$5.22M |
|
|
8
Pacira BioSciences
PCRX
$1,000M
| $31.2M | 1.82% |
1,002,311
+341,520
| +52% | +$12.2M |
|
9
Korn Ferry
KFY
$3.96B
| $28.8M | 1.68% |
559,047
-10,999
| -2% | -$490K |
|
|
IPHI
10
DELISTED
INPHI CORPORATION
IPHI
| $28.2M | 1.65% |
937,763
+442,240
| +89% | +$13.7M |
|
|
SNCR
11
DELISTED
Synchronoss Technologies
SNCR
| $27.4M | 1.6% |
288,551
+12,125
| +4% | +$995K |
|
|
EFII
12
DELISTED
Electronics for Imaging
EFII
| $26.7M | 1.56% |
977,566
+206,760
| +27% | +$5.93M |
|
|
IVC
13
DELISTED
Invacare Corporation
IVC
| $24.2M | 1.41% |
1,388,380
+480,755
| +53% | +$8.48M |
|
|
14
Sarepta Therapeutics
SRPT
$1.8B
| $24.1M | 1.41% |
325,356
-378,068
| -54% | -$25.2M |
|
|
NGHC
15
DELISTED
National General Holdings Corp
NGHC
| $24M | 1.4% |
985,703
-22,023
| -2% | -$474K |
|
16
Dycom Industries
DY
$12.5B
| $23.6M | 1.38% |
219,638
-4,186
| -2% | -$475K |
|
|
17
Chegg
CHGG
$88.6M
| $22.9M | 1.34% |
1,107,889
-820,787
| -43% | -$15.5M |
|
|
VCRA
18
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $22.8M | 1.33% |
972,699
+357,397
| +58% | +$9.56M |
|
19
Churchill Downs
CHDN
$5.9B
| $22.5M | 1.32% |
554,046
-10,530
| -2% | -$448K |
|
|
WWE
20
DELISTED
World Wrestling Entertainment
WWE
| $21.7M | 1.27% |
602,878
-13,507
| -2% | -$476K |
|
|
ICPT
21
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $21.4M | 1.25% |
+348,454
| New | +$21M |
|
|
WAGE
22
DELISTED
WageWorks, Inc.
WAGE
| $20.6M | 1.2% |
455,525
-8,699
| -2% | -$475K |
|
|
MDCO
23
DELISTED
Medicines Co
MDCO
| $20.3M | 1.19% |
616,577
-94,284
| -13% | -$2.95M |
|
24
Planet Fitness
PLNT
$4.17B
| $19.5M | 1.14% |
517,398
-11,645
| -2% | -$408K |
|
|
INFN
25
DELISTED
Infinera Corporation Common Stock
INFN
| $18.9M | 1.11% |
1,744,766
-141,120
| -7% | -$1.25M |
|
Similar funds
BAC
AVC
OWD
PP
WWM
JA
PL
EA
Elk Creek Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Elk Creek Partners held 168 positions worth $1.71B, up 0.7% from $1.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Elk Creek Partners's Q1 2018 filing shows 11 new, 69 increased, 76 reduced and 12 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 348,454 shares worth $21.4M. The largest sale was Blackhawk Network Holdings, Inc. Common Stock, an estimated $29.7M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.
- Elk Creek Partners's largest Q1 2018 buy was Intercept Pharmaceuticals, Inc.: 348,454 shares worth $21.4M.
- Elk Creek Partners added most to Exact Sciences in Q1 2018, an estimated $18.8M increase.
- Elk Creek Partners's biggest Q1 2018 reduction was Sarepta Therapeutics, cutting an estimated $25.2M.
- Elk Creek Partners fully exited Blackhawk Network Holdings, Inc. Common Stock in Q1 2018, selling an estimated $29.7M.
- Elk Creek Partners's ten largest holdings make up 22% of its $1.71B portfolio in Q1 2018.
- Elk Creek Partners opened 11 new positions and closed 12 in Q1 2018.
- Elk Creek Partners's portfolio value rose 0.7% quarter-over-quarter to $1.71B.
Based on Elk Creek Partners's 13F filing for Q1 2018, filed 11 May 2018.